ALTAMIR_REGISTRATION_DOCUMENT_2017
1
PRESENTATION OF THE COMPANY AND ITS ACTIVITIES
Presentation of the Company
1.2.3 PORTFOLIO
At 31 December 2017
Percentage interest in the underlying
Year of investment
operating company
Residual cost in €K
Stage of development
TMT (Technology – Media – Telecom) Marlink (1a) (2)
2016 2016 2016 2016 2008 2011 2017 2007 2017 2017 2016 2015 2016 2015 2015 2013
27.20% 20.90% 28.70% 35.17% 3.53% 17.10% 2.26% 2.54%
59,004 38,876 33,871 22,361 18,703 10,677 9,244 4,340 3,236 2,554 2,337 2,335
LBO LBO LBO LBO
InfoVista (1a) (2)
Melita (1a)
Nowo/Oni (1a)
Altran Technologies* (3)
Growth capital
Vocalcom (1a)
13,594 Growth capital
ThoughtWorks (1b) (2) Gfi Informatique* (3)
LBO LBO LBO LBO LBO LBO LBO LBO LBO LBO
ECi Software Solutions (1b)
1.41% 1.70% 0.49% 0.96% 0.57% 0.50% 0.22% 0.51%
Attenti (1b)
Engineering Ingegneria Informatica (1b)
Exact Software (1b)
Duck Creek Technologies (1b)
EVRY* (1b) Zensar* (1b)
1,173 1,126
GlobalLogic (1b)
624
224,055
HEALTHCARE Amplitude Surgical* (1a)
2011 2017 2017 2013 2016 2017 2016 2014 2015
13.42% 1.03% 1.62% 0.33% 0.90% 1.42% 0.48% 0.33% 0.63%
14,041 9,646 5,345 3,619 2,874 2,841 2,077
LBO LBO LBO LBO LBO LBO LBO LBO LBO
Unilabs (1b)
Syneron Candela (1b)
One Call Care Management (1b)
NuPharm365 (1b) (formerly Invent Neurax)
Kepro (1b)
Vyaire Medical (1b)
Genex (1b)
321 151
Ideal Protein (1b)
40,914
(1) Investments via the Apax funds. (1a) via the Apax France VIII and Apax France IX funds. (1b) via the Apax VIII LP and Apax IX LP funds. (2) Co-investments (alongside the Apax France VIII, Apax France IX and Apax IX LP funds). (3) Direct investments (legacy portfolio). * Listed company.
22 REGISTRATION DOCUMENT
• ALTAMIR 2017
www.altamir.fr
Made with FlippingBook - professional solution for displaying marketing and sales documents online